BIOCHROM LIMITED
Get an alert when BIOCHROM LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£448K
-13.9% lowest in 3 filed years
Net assets
£12M
-1.7% vs 2023
Employees
30
-14.3% lowest in 3 filed years
Profit before tax
-£14K
-101.4% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £12,185,885 | £10,979,446 | £8,901,558 | -18.9% | |
| Operating profit | £802,962 | £1,247,776 | £94,737 | -92.4% | |
| Profit before tax | £363,718 | £991,268 | -£13,768 | -101.4% | |
| Net profit | £363,718 | £991,268 | -£13,768 | -101.4% | |
| Cash | £470,619 | £520,575 | £448,415 | -13.9% | |
| Total assets less current liabilities | £11,920,588 | £12,474,674 | £11,672,798 | -6.4% | |
| Net assets | £11,844,963 | £12,392,549 | £12,186,673 | -1.7% | |
| Equity | £11,844,963 | £12,392,549 | £12,186,673 | -1.7% | |
| Average employees | 37 | 35 | 30 | -14.3% | |
| Wages | £1,832,782 | £1,799,253 | £1,757,199 | -2.3% | |
| Directors' remuneration | £168,960 | £143,738 | £182,493 | +27% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Operating margin | 6.6% | 11.4% | 1.1% | |
| Net margin | 3.0% | 9.0% | -0.2% | |
| Return on capital employed | 6.7% | 10.0% | 0.8% | |
| Current ratio | 1.18x | 1.38x | 1.40x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- BIOCHROM LIMITED 1998-03-26 → present
- INTERCEDE 1313 LIMITED 1998-03-13 → 1998-03-26
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of their assessment of the Company's financial position and of the enquiries made of the directors of the ultimate parent undertaking, the Company's directors have a reasonable expectation that the Company will be able to continue in operational existence and meet its liabilities as they fall due for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing these financial statements.”
Group structure
- BIOCHROM LIMITED · parent
- Scie-Plas Limited 100%
- Asys Hitech GmbH 100%
- Walden Precision Apparatus Limited 100%
- CMA Microdialysis AB 100%
- Multi Channel Systems GmbH 100%
Significant events
- “In October 2025, the Company's previously completed bulk annuity transaction with Just Group Plc for its Harvard Apparatus Limited Retirement Benefit Scheme was converted to a buy-out contract. The scheme expects to wind-up during 2026.”
- “In January 2026, the Company's parent, Harvard Bioscience Inc., announced its strategic consolidation of manufacturing operations to improve efficiency and support long-term growth. As part of this announcement the Company will be bringing in the manufacture of specific product lines to the UK as the designated centre of excellence.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 23 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FOLLEN, Leigh Edward | Secretary | 2020-11-24 | — | — |
| EYLES, Joe Joseph | Director | 2014-09-23 | Jul 1972 | British |
| KARCHER, Felix | Director | 2025-08-29 | Sep 1993 | German |
Show 23 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CZARNOBAJ, Michael David | Secretary | 1999-03-01 | 2001-05-04 |
| EYLES, Joe Joseph | Secretary | 2013-11-20 | 2020-11-24 |
| PETHER, Howard David James | Secretary | 2012-03-01 | 2013-11-20 |
| RINALDI, Philip | Secretary | 2001-10-25 | 2012-02-29 |
| TURNER, Nigel Paul | Secretary | 2001-05-04 | 2001-08-16 |
| MITRE SECRETARIES LIMITED | Corporate Nominee Secretary | 1998-03-13 | 1999-03-01 |
| BROWN, William Barry | Director | 1999-03-01 | 2000-07-13 |
| COTE, Jennifer Siony | Director | 2024-08-20 | 2025-08-29 |
| DUCHEMIN, Jeffrey | Director | 2013-11-20 | 2019-09-30 |
| FRY, John James | Director | 2024-08-20 | 2025-08-29 |
| GAGNON, Robert | Director | 2013-11-20 | 2018-08-31 |
| GRAZIANO, Chancey Lee | Director | 1999-03-01 | 2013-11-20 |
| GREEN, David | Director | 1999-03-01 | 2013-11-20 |
| GREEN, James Walter | Director | 2019-09-30 | 2025-08-29 |
| HEFFERNAN, James Gerard, Dr | Director | 2008-01-08 | 2010-05-14 |
| HOUSE, John Anthony | Director | 2000-07-13 | 2001-12-31 |
| LUKE, Samuel James | Director | 2010-07-12 | 2014-03-19 |
| PARR, David Michael | Director | 2001-02-12 | 2008-01-11 |
| PETHER, Howard David James | Director | 2013-11-20 | 2014-09-12 |
| REEVES, Barbara | Nominee Director | 1998-03-13 | 1999-03-01 |
| RICH, Michael William | Nominee Director | 1998-03-13 | 1999-03-01 |
| STIFTER, Francis Jerome | Director | 2020-09-02 | 2024-08-20 |
| UNNINAYAR, Kamalam | Director | 2018-11-26 | 2019-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Harvard Bioscience, Inc | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 149 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-21 | AA | accounts | Accounts with accounts type full | |
| 2026-04-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-10 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-10 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-10 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-06 | AA | accounts | Accounts with accounts type full | |
| 2025-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-27 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-22 | AA | accounts | Accounts with accounts type full | |
| 2023-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-11 | AA | accounts | Accounts with accounts type full | |
| 2022-03-24 | AD02 | address | Change sail address company with old address new address | |
| 2022-03-24 | AD02 | address | Change sail address company with old address new address | |
| 2022-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-03 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.